<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-35600" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hypertensive Retinopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Modi</surname>
            <given-names>Pranav</given-names>
          </name>
          <aff>DY Patil Hospital, Navi Mumbai, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Arsiwalla</surname>
            <given-names>Tasneem</given-names>
          </name>
          <aff>Sankara Eye Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pranav Modi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tasneem Arsiwalla declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-35600.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Poorly controlled hypertension (HTN) affects several systems such as the cardiovascular, renal, cerebrovascular, and retina. The damage to these systems is known as target-organ damage (TOD). HTN affects the eye causing 3 types of ocular damage: choroidopathy, retinopathy, and optic neuropathy. This activity reviews the cause and pathophysiology og hypertensive retinopathy and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the stages of hypertensive retinopathy.</p></list-item><list-item><p>Review the presentation of hypertensive retinopathy.</p></list-item><list-item><p>Outline the treatment and management options available for hypertensive retinopathy.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and outcomes in patients with hypertensive retinopathy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=35600&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=35600">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-35600.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Poorly controlled hypertension (HTN) affects several systems such as the cardiovascular, renal, cerebrovascular, and retina. The damage to these systems is known as target-organ damage (TOD).<xref ref-type="bibr" rid="article-35600.r1">[1]</xref>&#x000a0;HTN affects the eye&#x000a0;causing 3 types of ocular damage: choroidopathy, retinopathy, and optic neuropathy.<xref ref-type="bibr" rid="article-35600.r2">[2]</xref>&#x000a0;Hypertensive retinopathy (HR) occurs when the retinal vessels get damaged due to elevated blood pressure. There has been significant evidence that&#x000a0;hypertensive retinopathy acts as a predictor of systemic morbidity and mortality due to TOD.<xref ref-type="bibr" rid="article-35600.r1">[1]</xref>&#x000a0;A study by Erden et al. showed that the increase in the incidence of retinopathy is related to the degree of&#x000a0;severity and duration of HTN.<xref ref-type="bibr" rid="article-35600.r3">[3]</xref></p>
      </sec>
      <sec id="article-35600.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Apart from essential and secondary hypertension, there are other factors which play an important role in the development of&#x000a0;hypertensive retinopathy. The prevalence of&#x000a0;hypertensive retinopathy&#x000a0;is more in Afro-Caribbean as compared to Europeans and more in women as compared to men. Genetic factors can also play a role with certain genotypes associated with an increased risk of&#x000a0;hypertensive retinopathy.<xref ref-type="bibr" rid="article-35600.r4">[4]</xref> Pontremoli et al. studied the genetic factors linked to&#x000a0;hypertensive retinopathy and found the deletion of the allele of the&#x000a0;angiotensin-converting enzyme has a higher risk associated with the development of&#x000a0;hypertensive retinopathy.<xref ref-type="bibr" rid="article-35600.r5">[5]</xref>&#x000a0;Smoking is considered to have a strong association with severe or malignant&#x000a0;hypertensive retinopathy as studied by Poulter et al.<xref ref-type="bibr" rid="article-35600.r6">[6]</xref> Renal dysfunction (persistent microalbuminuria and low creatinine clearance) in patients has shown to be a marker for&#x000a0;hypertensive retinopathy and end-organ damage.<xref ref-type="bibr" rid="article-35600.r7">[7]</xref>&#x000a0;Uckaya et al. found an association with plasma leptin. It was observed that plasma leptin levels were higher in patients with hypertensive retinopathy and postulated that it is associated with vascular endothelium damage.<xref ref-type="bibr" rid="article-35600.r8">[8]</xref></p>
      </sec>
      <sec id="article-35600.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The severity and duration of hypertension are directly proportional to the incidence of&#x000a0;hypertensive retinopathy as studied by Erden et al. The incidence of&#x000a0;hypertensive retinopathy&#x000a0;in their study was 66.3%<xref ref-type="bibr" rid="article-35600.r3">[3]</xref>.&#x000a0;Kabedi&#x000a0;et al. stated hypertensive retinopathy incidence of 83.6% out of the total hypertensive patients and found chronic kidney disease to be the&#x000a0;most significant factor to predict severe&#x000a0;hypertensive retinopathy.<xref ref-type="bibr" rid="article-35600.r1">[1]</xref>&#x000a0;As per the study conducted by Del Brutto et al.,&#x000a0;hypertensive retinopathy grade 1 was&#x000a0;recorded in 37%, and grade 2&#x000a0;hypertensive retinopathy&#x000a0;was noted in 17% of hypertensive patients.<xref ref-type="bibr" rid="article-35600.r9">[9]</xref></p>
      </sec>
      <sec id="article-35600.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Retinal blood vessels have distinct features, which differentiate them from other blood vessels<xref ref-type="bibr" rid="article-35600.r10">[10]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>&#x000a0;The absence of sympathetic nerve supply</p>
          </list-item>
          <list-item>
            <p>&#x000a0;Autoregulation of blood flow</p>
          </list-item>
          <list-item>
            <p>&#x000a0;Presence of blood-retinal barrier</p>
          </list-item>
        </list>
        <p>Thus, an increase in blood pressure (BP) is transferred directly to the vessels which initially constrict. However, a further increase in BP overcomes this compensatory tone and damage to the muscle layer and endothelium ensues.</p>
        <p>Hypertensive retinopathy has the following phases<xref ref-type="bibr" rid="article-35600.r2">[2]</xref>:</p>
        <p>
<bold>Vasoconstrictive Phase</bold>
</p>
        <p>In this phase, the local autoregulatory mechanisms come into play. This causes vasospasm and retinal arteriole narrowing, which is evident by the decrease in the arteriole to venule ratio (Normal = 2:3). In older patients with arteriosclerosis, focal arteriolar narrowing develops, as affected vascular segments cannot undergo narrowing.</p>
        <p>
<bold>Sclerotic Phase</bold>
</p>
        <p>Persistent increase in BP causes certain changes in vessel wall:</p>
        <list list-type="bullet">
          <list-item>
            <p>Intima layer: Thickening</p>
          </list-item>
          <list-item>
            <p>Media layer: Hyperplasia</p>
          </list-item>
          <list-item>
            <p>Arteriolar wall: Hyaline degeneration</p>
          </list-item>
        </list>
        <p>This leads to a severe form of arteriolar narrowing, arteriovenous (AV) crossing changes, and widening and accentuation of light reflex (silver and copper wiring). AV crossing changes occur when a thickened arteriole crosses over a venule and subsequently compresses it as the vessels share a common adventitious sheath. The vein, in turn, appears dilated and torturous distal to the AV crossing.</p>
        <p>
<bold>Exudative Phase</bold>
</p>
        <p>Seen in patients with severely increased BP; characterized by the disruption of the blood-brain barrier and leakage of blood and plasma into the vessel wall disrupting the autoregulatory mechanisms. In this stage, retinal signs occur such as retinal hemorrhage (flame-shaped and dot blot), hard exudate formation, necrosis of smooth muscle cells and retinal ischemia (cotton-wool spots).</p>
        <p>
<bold>Malignant Hypertension</bold>
</p>
        <p>Severe intracranial hypertension leads to optic nerve ischemia and edema (papilledema). Also, fibrinoid necrosis of choroidal arterioles occurs leading to segmental infarction of choriocapillaries. This gives rise to:</p>
        <list list-type="bullet">
          <list-item>
            <p>Elschnig's spots: Where the overlying retinal pigment epithelium (RPE) appears yellow</p>
          </list-item>
          <list-item>
            <p>Siegrist's streak: RPE hyperplasia over choroidal infarcts</p>
          </list-item>
          <list-item>
            <p>Neurosensory RPE detachments</p>
          </list-item>
        </list>
        <p>These signs are termed as choroidopathy.</p>
      </sec>
      <sec id="article-35600.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Clinical Features</bold>
<xref ref-type="bibr" rid="article-35600.r4">[4]</xref>
</p>
        <p>Hypertensive retinopathy is usually asymptomatic and is diagnosed on fundoscopic features. The following are signs of hypertensive retinopathy.</p>
        <p>
<bold>
<italic toggle="yes">AV Crossing Changes</italic>
</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Salus&#x02019;s sign: Deflection of retinal vein as it crosses the arteriole.</p>
          </list-item>
          <list-item>
            <p>Gunn&#x02019;s sign: Tapering of the retinal vein on either side of the AV crossing.</p>
          </list-item>
          <list-item>
            <p>Bonnet&#x02019;s sign: Banking of the retinal vein distal to the AV crossing.</p>
          </list-item>
        </list>
        <p>
<bold>
<italic toggle="yes">Arterial Changes</italic>
</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Decrease in the arteriovenous ratio to 1:3 (&#x000a0;the normal ratio is 2:3).&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Change in the arteriolar light reflex (light reflex appears as copper and/or silver wiring)</p>
          </list-item>
        </list>
        <p>
<bold>
<italic toggle="yes">Retinal Changes</italic>
</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Retinal hemorrhages:&#x000a0;</italic>
<list list-type="bullet"><list-item><p>Dot-blot hemorrhages: Bleeding in the inner retinal layer</p></list-item><list-item><p>Flame shaped hemorrhage: Bleeding is in the superficial retinal layer</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Retinal exudates:</italic>
<list list-type="bullet"><list-item><p>Hard exudates: Lipid deposits in the retina</p></list-item><list-item><p>Soft exudates: These are also known as cotton wool spots which appear due to ischemia of the nerve fibers</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>
<bold>
<italic toggle="yes">Macular Changes</italic>
</bold>
</p>
        <p>Macular star formation due to deposition of hard exudates around the macula.</p>
        <p>
<bold>
<italic toggle="yes">Optic Nerve Changes</italic>
</bold>
</p>
        <p>Optic disk swelling (also known as hypertensive optic neuropathy)</p>
        <p>In a study by Wong et al., they identified certain retinal signs to be associated with increased risk for stroke. The signs are AV nicking, focal arteriolar narrowing (as this is associated with arteriosclerosis), microaneurysms, cotton wool spots, retinal hemorrhages (dot blot and flame-shaped), and decreased AV ratio.<xref ref-type="bibr" rid="article-35600.r11">[11]</xref></p>
      </sec>
      <sec id="article-35600.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Classification</bold>
</p>
        <p>The following are classification systems for hypertensive retinopathy based on fundus examination with indirect ophthalmoscopy or +90 D lens.&#x000a0;</p>
        <p>
<italic toggle="yes">
<bold>Keith-Wagner- Barker classification</bold>
</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Group 1:&#x000a0;Slight constriction of retinal arterioles</p>
          </list-item>
          <list-item>
            <p>Group 2:&#x000a0;Group 1 + focal narrowing of retinal arterioles + AV nicking</p>
          </list-item>
          <list-item>
            <p>Group 3:&#x000a0;Group 2 + flame-shaped haemorrhages + cotton-wool spots + hard exudates</p>
          </list-item>
          <list-item>
            <p>Group 4:&#x000a0;Group 3 + optic disc swelling</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">
<bold>Scheie Classification</bold>
</italic>
</p>
        <p>
<italic toggle="yes">For Hypertensive Retinopathy</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage 0:&#x000a0;No visible abnormalities</p>
          </list-item>
          <list-item>
            <p>Stage 1:&#x000a0;Diffuse arteriolar narrowing</p>
          </list-item>
          <list-item>
            <p>Stage 2:&#x000a0;Stage 1 + focal arteriolar constriction</p>
          </list-item>
          <list-item>
            <p>Stage 3: Stage 2 + retinal hemorrhage</p>
          </list-item>
          <list-item>
            <p>Stage 4:&#x000a0; Stage 3 + hard exudates + retinal edema+ optic disc swelling</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">For Arteriosclerosis</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage 0: Normal</p>
          </list-item>
          <list-item>
            <p>Stage 1:&#x000a0;Broadening of arteriolar light reflex</p>
          </list-item>
          <list-item>
            <p>Stage 2: Stage 1 + AV crossing changes</p>
          </list-item>
          <list-item>
            <p>Stage 3:&#x000a0;Copper wiring of arterioles</p>
          </list-item>
          <list-item>
            <p>Stage 4: Silver wiring of arterioles</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35600.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The main purpose of screening for hypertensive retinopathy is that retinal vessels are the only blood vessels visible on routine examination. The effects of chronically elevated HTN are easily visible in the eye as hypertensive retinopathy and choroidopathy, and this reflects the vascular changes occurring in other systems.&#x000a0;Ophthalmologists and general physicians should work in collaborations to ensure that hypertensive patients are efficiently screened, and timely managed to reduce the risk of ocular and systemic morbidity and mortality.<xref ref-type="bibr" rid="article-35600.r12">[12]</xref>&#x000a0;Henderson et al., however, noted that&#x000a0;Hypertensive retinopathy is associated with an increased risk of stroke even after controlling BP and other vascular risk factors.<xref ref-type="bibr" rid="article-35600.r2">[2]</xref></p>
        <p>The management of hypertensive retinopathy depends on the severity of the disease:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Mild hypertensive retinopathy:</italic> The treatment consists of controlling of BP with regular monitoring.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Moderate hypertensive retinopathy:</italic> Referral to a physician is essential to exclude other associated factors like diabetes mellitus and to check for any cardiovascular abnormalities. Routine care including BP control and monitoring is a must.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Severe hypertensive retinopathy:</italic> Requires urgent treatment and referral as it has the strongest association with mortality. Other systems such as renal, cardiovascular, and brain should be monitored for signs of TOD.</p>
          </list-item>
        </list>
        <p>Important to note is that BP should be lowered in a controlled fashion. This is crucial to prevent ischemic damage to vital organs such as optic nerve and brain.</p>
      </sec>
      <sec id="article-35600.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The other conditions which present with optic disc swelling are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Diabetic papillopathy</p>
          </list-item>
          <list-item>
            <p>Central retinal vein occlusion</p>
          </list-item>
          <list-item>
            <p>Anterior ischemic optic neuropathy</p>
          </list-item>
          <list-item>
            <p>Neuroretinitis</p>
          </list-item>
        </list>
        <p>Conditions which mimic chronic hypertensive retinopathy are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Diabetic retinopathy</p>
          </list-item>
          <list-item>
            <p>Retinal venous obstruction</p>
          </list-item>
          <list-item>
            <p>Hyperviscosity syndrome</p>
          </list-item>
          <list-item>
            <p>Ocular ischemic syndrome</p>
          </list-item>
          <list-item>
            <p>Radiation retinopathy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35600.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Chronic hypertensive retinopathy rarely causes significant visual loss. The retinal changes can be halted when hypertension is treated. However, arteriolar narrowing and AV changes persist. For untreated malignant hypertension, the mortality is high as 50% within 2 months of diagnosis and almost 90% by the end of 1 year.<xref ref-type="bibr" rid="article-35600.r13">[13]</xref> Vision loss in hypertensive retinopathy is because of either secondary optic atrophy after prolonged papilloedema or retinal pigmentary changes after exudative retinal detachment.</p>
      </sec>
      <sec id="article-35600.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications include<xref ref-type="bibr" rid="article-35600.r14">[14]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Retinal artery occlusion</p>
          </list-item>
          <list-item>
            <p>Retinal vein occlusion</p>
          </list-item>
          <list-item>
            <p>Macro aneurysm of retinal arteriole</p>
          </list-item>
          <list-item>
            <p>Diabetic retinopathy (DR): Both&#x000a0;hypertensive&#x000a0;retinopathy and DR&#x000a0;together in a patient is called as mixed retinopathy. HTN is also known to be a major risk factor for the progression of DR.</p>
          </list-item>
          <list-item>
            <p>Anterior ischemic optic neuropathy</p>
          </list-item>
          <list-item>
            <p>Age-related macular degeneration</p>
          </list-item>
          <list-item>
            <p>Glaucoma</p>
          </list-item>
          <list-item>
            <p>Retinal arteriolar emboli</p>
          </list-item>
          <list-item>
            <p>Epiretinal membrane formation</p>
          </list-item>
          <list-item>
            <p>Cystoid macular edema</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-35600.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Hypertension has effects on multiple systems, and it is important to have care coordination between the physician, physician assistant, nurse practitioner, ophthalmologist, nephrologist, and cardiologist to ensure early detection and control of hypertension and improve patient outcomes. Patients with hypertension need to be informed that they should follow up regularly with an ophthalmologist for a complete eye assessment. In addition, patients need to be educated about the importance of compliance with antihypertensive medications.<xref ref-type="bibr" rid="article-35600.r15">[15]</xref> (Level V)</p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>In most patients, hypertensive retinopathy does not cause vision loss as long as the hypertension is treated. However, if the blood pressure remains untreated, it can lead to vision loss within a short period of&#x000a0;time. The cause of the vision loss is&#x000a0;either&#x000a0;due to retinal pigmentary changes or secondary to optic atrophy, neither of which is reversible. <xref ref-type="bibr" rid="article-35600.r16">[16]</xref>(Level V)&#x000a0;</p>
      </sec>
      <sec id="article-35600.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=35600&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=35600">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/hypertensive-retinopathy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=35600">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/35600/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=35600">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-35600.s14">
        <fig id="article-35600.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Hypertensive Retinopathy Contributed by Pranav Modi</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Hypertensive__Retinopathy" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-35600.s15">
        <title>References</title>
        <ref id="article-35600.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kabedi</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Mwanza</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Lepira</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Kayembe</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Kayembe</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Hypertensive retinopathy and its association with cardiovascular, renal and cerebrovascular morbidity in Congolese patients.</article-title>
            <source>Cardiovasc J Afr</source>
            <year>2014</year>
            <season>Sep-Oct</season>
            <volume>25</volume>
            <issue>5</issue>
            <fpage>228</fpage>
            <page-range>228-32</page-range>
            <pub-id pub-id-type="pmid">25629539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henderson</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Bruce</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Biousse</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Hypertension-related eye abnormalities and the risk of stroke.</article-title>
            <source>Rev Neurol Dis</source>
            <year>2011</year>
            <volume>8</volume>
            <issue>1-2</issue>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">21769065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erden</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bicakci</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Hypertensive retinopathy: incidence, risk factors, and comorbidities.</article-title>
            <source>Clin Exp Hypertens</source>
            <year>2012</year>
            <volume>34</volume>
            <issue>6</issue>
            <fpage>397</fpage>
            <page-range>397-401</page-range>
            <pub-id pub-id-type="pmid">22468968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chatterjee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chattopadhyay</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hope-Ross</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lip</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Hypertension and the eye: changing perspectives.</article-title>
            <source>J Hum Hypertens</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>10</issue>
            <fpage>667</fpage>
            <page-range>667-75</page-range>
            <pub-id pub-id-type="pmid">12420190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pontremoli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sofia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tirotta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ravera</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nicolella</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Viazzi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bezante</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Borgia</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bobola</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ravazzolo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sacchi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Deferrari</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension.</article-title>
            <source>J Am Soc Nephrol</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>12</issue>
            <fpage>2550</fpage>
            <page-range>2550-8</page-range>
            <pub-id pub-id-type="pmid">8989733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poulter</surname>
                <given-names>NR</given-names>
              </name>
            </person-group>
            <article-title>Independent effects of smoking on risk of hypertension: small, if present.</article-title>
            <source>J Hypertens</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>171</fpage>
            <page-range>171-2</page-range>
            <pub-id pub-id-type="pmid">11821697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biesenbach</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zazgornik</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy.</article-title>
            <source>Clin Nephrol</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>211</fpage>
            <page-range>211-8</page-range>
            <pub-id pub-id-type="pmid">8026113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uckaya</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ozata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sonmez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kinalp</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Eyileten</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bingol</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Koc</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kocabalkan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ozdemir</surname>
                <given-names>IC</given-names>
              </name>
            </person-group>
            <article-title>Is leptin associated with hypertensive retinopathy?</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>85</volume>
            <issue>2</issue>
            <fpage>683</fpage>
            <page-range>683-7</page-range>
            <pub-id pub-id-type="pmid">10690876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Del Brutto</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Mera</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Viteri</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>P&#x000f3;lit</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ledesma</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Cano</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Plaza</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Zambrano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Hypertensive retinopathy and cerebral small vessel disease in Amerindians living in rural Ecuador: The Atahualpa Project.</article-title>
            <source>Int J Cardiol</source>
            <year>2016</year>
            <month>Sep</month>
            <day>01</day>
            <volume>218</volume>
            <fpage>65</fpage>
            <page-range>65-68</page-range>
            <pub-id pub-id-type="pmid">27232913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaine</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kohner</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>[Hypertensive retinopathy].</article-title>
            <source>J Fr Ophtalmol</source>
            <year>1983</year>
            <volume>6</volume>
            <issue>12</issue>
            <fpage>995</fpage>
            <page-range>995-1005</page-range>
            <pub-id pub-id-type="pmid">6674324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Couper</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Shahar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hubbard</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Wofford</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Sharrett</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study.</article-title>
            <source>Lancet</source>
            <year>2001</year>
            <month>Oct</month>
            <day>06</day>
            <volume>358</volume>
            <issue>9288</issue>
            <fpage>1134</fpage>
            <page-range>1134-40</page-range>
            <pub-id pub-id-type="pmid">11597667</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fraser-Bell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Symes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vaze</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hypertensive eye disease: a review.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-53</page-range>
            <pub-id pub-id-type="pmid">27990740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keith</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Wagener</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>NW</given-names>
              </name>
            </person-group>
            <article-title>Some different types of essential hypertension: their course and prognosis.</article-title>
            <source>Am J Med Sci</source>
            <year>1974</year>
            <month>Dec</month>
            <volume>268</volume>
            <issue>6</issue>
            <fpage>336</fpage>
            <page-range>336-45</page-range>
            <pub-id pub-id-type="pmid">4616627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhargava</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ikram</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>TY</given-names>
              </name>
            </person-group>
            <article-title>How does hypertension affect your eyes?</article-title>
            <source>J Hum Hypertens</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>71</fpage>
            <page-range>71-83</page-range>
            <pub-id pub-id-type="pmid">21509040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Audebert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Laumeier</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ahmadi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Steinicke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferse</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Michelson</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Telemedical assessment of optic nerve head and retina in patients after recent minor stroke or TIA.</article-title>
            <source>Int Ophthalmol</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-46</page-range>
            <pub-id pub-id-type="pmid">27016938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-35600.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Do</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Vedula</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Marrone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sleilati</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Frank</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Blood pressure control for diabetic retinopathy.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2015</year>
            <month>Jan</month>
            <day>31</day>
            <volume>1</volume>
            <fpage>CD006127</fpage>
            <pub-id pub-id-type="pmid">25637717</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
